Q32 Bio (QTTB) Cash from Investing Activities (2017 - 2025)

Q32 Bio's Cash from Investing Activities history runs 9 years deep, the most recent figure standing at $7.0 million for Q4 2025.

• In Q4 2025, Cash from Investing Activities rose 350100.0% year-over-year to $7.0 million; the TTM figure through Mar 2026 stood at $7.0 million (down 64.7% YoY), while the FY2025 annual figure was $7.0 million, down 64.87% from the prior year.
• Cash from Investing Activities was $7.0 million for Q4 2025 at Q32 Bio, up from -$2000.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $168.3 million in Q1 2022 to a low of -$108.2 million in Q3 2022.
• Historically, Cash from Investing Activities has averaged $803000.0 across 5 years, with a median of $49000.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities tumbled 2492.09% in 2022, then soared 994300.0% in 2024.
• A 5-year view of Cash from Investing Activities shows it stood at $43.7 million in 2021, then tumbled by 58.79% to $18.0 million in 2022, then tumbled by 100.01% to -$1000.0 in 2023, then slumped by 100.0% to -$2000.0 in 2024, then jumped by 350100.0% to $7.0 million in 2025.
• The last three Cash from Investing Activities figures came in at $7.0 million (Q4 2025), -$2000.0 (Q4 2024), and $9.9 million (Q3 2024), per Business Quant data.